Jaundice Phototherapy Machine segmentation by type distinguishes four technological families: LED‑based systems, Fluorescent‑lamp units, Bilirubinometer‑integrated devices, and Portable battery‑operated models. LED‑based systems, accounting for roughly 45 % of global sales, leverage narrow‑band light at 460 nm, delivering higher efficacy with lower heat output; their longer service life and reduced energy consumption justify a premium price point, influencing overall market valuation. Fluorescent‑lamp units, still representing about 35 % of shipments, rely on broadband emission and are favored in cost‑sensitive hospital contracts, though they require more frequent bulb replacement, affecting total cost of ownership. Bilirubinometer‑integrated devices combine phototherapy with real‑time bilirubin measurement, comprising approximately 15 % of the market; this convergence supports clinical decision‑making and commands higher margins. Portable battery‑operated models, primarily used in home‑care, make up the remaining 5 %; their lightweight design and cordless operation address discharge protocols but involve trade‑offs in intensity and treatment duration. Each type contributes distinct cost structures and adoption drivers, collectively shaping the market’s revenue composition.
